[1] Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis[J]. Circulation, 2002, 105(9):1135-1143. [2] Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis[J]. Circ Res, 2016, 118(4):692-702. [3] Angeles-Martínez J, Posadas-Sánchez R,Álvarez-León E, et al. Monocyte chemoattractant protein-1 gene (MCP-1) polymorphisms are associated with risk of premature coronary artery disease in Mexican patients from the genetics of atherosclerotic disease (GEA) study[J]. Immunol Lett, 2015, 167(2):125-130. [4] Wan W, Murphy PM. Regulation of atherogenesis by chemokines and chemokine receptors[J]. Arch Immunol Ther Exp (Warsz), 2013, 61(1):1-14. [5] Yu B, Wong MM, Potter CM, et al. Vascular stem/progenitor cell migration induced by smooth muscle cell derived chemokine (C-C motif) ligand 2 and chemokine (C-X-C motif) ligand 1 contributes to neointima formation[J]. Stem Cells, 2016, 34(9):2368-2380. [6] Liu XL, Zhang PF, Ding SF, et al. Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice[J]. PLoS One, 2012, 7(3):e33497. [7] Meng F, Deng Z, Ni J. Interleukin-1 beta, tumor necrosis factor-alpha and lipopolysaccharide induce expression of monocyte chemoattractant protein-1 in calf aortic smooth muscle cells[J]. J Tongji Med Univ, 2000, 20(1):36-38. [8] Ren J, Wang Q, Morgan S, et al. Protein kinase C-δ (PKCδ) regulates proinflammatory chemokine expression through cytosolic interaction with the NF-κB subunit p65 in vascular smooth muscle cells[J]. J Biol Chem, 2014, 289(13):9013-9026. [9] Takahashi K, Takeya M, Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals[J]. Med Electron Microsc, 2002, 35(4):179-203. [10] Davenport AP, Hyndman KA, Dhaun N, et al. Endothelin[J]. Pharmacol Rev, 2016, 68(2):357-418. [11] Browatzki M, Schmidt J, Kübler W, et al. Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kB in human vascular smooth muscle cells[J]. Basic Res Cardiol, 2000, 95(2):98-105. [12] Montezano AC, Amiri F, Tostes RC, et al. Inhibitory effects of PPAR-gamma on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats[J]. J Am Soc Hypertens, 2007, 1(2):150-160. [13] 孟立平, 蒋承建, 赵飞, 等. 大鼠胸主动脉血管平滑肌细胞原代培养方法的改进[J]. 温州医科大学学报, 2015, 45(8):593-596. [14] 杜瑞雪, 叶平, 颜光涛, 等. 瑞舒伐他汀对颈动脉粥样硬化患者单个核细胞CCR2表达的影响及机制[J]. 中国应用生理学杂志, 2016, 32(3):202-206. [15] Stjernquist M. Endothelins-vasoactive peptides and growth factors[J]. Cell Tissue Res, 1998, 292(1):1-9. [16] Ivey ME, Osman N, Little PJ. Endothelin-1 signalling in vascular smooth muscle:pathways controlling cellular functions associated with atherosclerosis[J]. Atherosclerosis, 2008, 199(2):237-247. [17] 张静, 楚海荣, 郭英, 等. 高糖对大鼠血管平滑肌细胞表型转化的影响及其机制[J]. 中国应用生理学杂志, 2015, 31(5):458-461. [18] Little PJ, Ivey ME, Osman N. Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosis[J]. Curr Vasc Pharmacol, 2008, 6(3):195-203. |